T. Kuzel

Multicenter phase II trial of interleukin-2, interferon-alpha, and 13-cis-retinoic acid in patients with metastatic renal-cell carcinoma.

Walter M. Stadler, T. Kuzel, M Dumas et al. · Journal of Clinical Oncology · 1998 · 71 citations

Medicine, Oncology, Pharmacology +17

A multi-institutional phase II trial of gemcitabine plus paclitaxel in patients with locally advanced or metastatic urothelial cancer

Donald S. Kaufman, Michael A. Carducci, T. Kuzel et al. · Urologic Oncology Seminars and Original Investigations · 2004 · 61 citations

Medicine, Oncology, Pharmacology +13

Vorinostat (suberoylanilide hydroxamic acid, SAHA) is clinically active in advanced cutaneous T-cell lymphoma (CTCL): Results of a phase IIb trial

EGJ Olsen, Y. H. Kim, T. Kuzel et al. · Journal of Clinical Oncology · 2006 · 40 citations

Medicine, Oncology, Pharmacology +14

QOL and outcomes research in prostate cancer patients with low socioeconomic status.

Simon P. Kim, C. L. Bennett, Clw Chan et al. · PubMed · 1999 · 26 citations

Pharmacy, Oncology, Health Services Research +16

Correlation of clinical responses with immunologic and morphologic characteristics in patients with cutaneous T-cell lymphoma treated with interferon alfa-2a

Elizabeth A. Springer, T. Kuzel, Daina Variakojis et al. · Journal of the American Academy of Dermatology · 1993 · 14 citations

Medicine, Immunology, Oncology +17